Other Species / Isoforms
  PPP2R5D (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
P2
______MPYKLKKEK
0 1
PPP2R5D (human) ______MPYKLKKEK P2
PPP2R5D (mouse) ______MsyKLKKDK S2-p
PPP2R5D (rat) GCGPAEMPYKLKKDK P29
Y3
_____MPYKLKKEKE
0 1
PPP2R5D (human) _____MPYKLKKEKE Y3
PPP2R5D (mouse) _____MsyKLKKDKQ Y3-p
PPP2R5D (rat) CGPAEMPYKLKKDKE Y30
T18-p
PPKVAKCtAKPSSSG
0 1
PPP2R5D (human) PPKVAKCtAKPSSSG T18-p
PPP2R5D (mouse) PSKLAKGTAKPSSSS T19
PPP2R5D (rat) PPKLAKGTAKPSSSS T45
T33
KDGGGENTEEAQPQP
0 1
PPP2R5D (human) KDGGGENTEEAQPQP T33
PPP2R5D (mouse) KDGGGENtDEAQPQP T34-p
PPP2R5D (rat) KDGGGENTDTEAQPQ T60
S50
QPQPQAQSQPPsSNK
0 2
PPP2R5D (human) QPQPQAQSQPPsSNK S50
PPP2R5D (mouse) EAQPQPQsQsPssNK S43-p
PPP2R5D (rat) gap -
P52
QPQAQSQPPsSNKRP
0 10
PPP2R5D (human) QPQAQSQPPsSNKRP P52
PPP2R5D (mouse) QPQPQsQsPssNKRP S45-p
PPP2R5D (rat) QPQPQPQPPSSNKRP P72
S54-p
QAQSQPPsSNKRPsN
0 2
PPP2R5D (human) QAQSQPPsSNKRPsN S54-p
PPP2R5D (mouse) QPQsQsPssNKRPsN S47-p
PPP2R5D (rat) QPQPQPPSSNKRPSN S74
S55
AQSQPPsSNKRPsNs
0 2
PPP2R5D (human) AQSQPPsSNKRPsNs S55
PPP2R5D (mouse) PQsQsPssNKRPsNS S48-p
PPP2R5D (rat) PQPQPPSSNKRPSNS S75
S60-p
PsSNKRPsNstPPPt
Upstream
Downstream
5 0
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • Chk1 (human)
  • PKACA (human)
Putative in vivo kinases:
  • Chk1 (human)
PPP2R5D (human) PsSNKRPsNstPPPt S60-p
PPP2R5D (mouse) PssNKRPsNStPPPT S53-p
PPP2R5D (rat) PSSNKRPSNSTPPPT S80
S62-p
SNKRPsNstPPPtQL
0 4
PPP2R5D (human) SNKRPsNstPPPtQL S62-p
PPP2R5D (mouse) sNKRPsNStPPPTQL S55
PPP2R5D (rat) SNKRPSNSTPPPTQL S82
T63-p
NKRPsNstPPPtQLS
0 11
PPP2R5D (human) NKRPsNstPPPtQLS T63-p
PPP2R5D (mouse) NKRPsNStPPPTQLS T56-p
PPP2R5D (rat) NKRPSNSTPPPTQLS T83
T67-p
sNstPPPtQLSkIky
0 1
PPP2R5D (human) sNstPPPtQLSkIky T67-p
PPP2R5D (mouse) sNStPPPTQLSKIKY T60
PPP2R5D (rat) SNSTPPPTQLSKIKY T87
K71-ub
PPPtQLSkIkysGGP
0 1
PPP2R5D (human) PPPtQLSkIkysGGP K71-ub
PPP2R5D (mouse) PPPTQLSKIKYsGGP K64
PPP2R5D (rat) PPPTQLSKIKYSGGP K91
K73-ub
PtQLSkIkysGGPQI
0 1
PPP2R5D (human) PtQLSkIkysGGPQI K73-ub
PPP2R5D (mouse) PTQLSKIKYsGGPQI K66
PPP2R5D (rat) PTQLSKIKYSGGPQI K93
Y74-p
tQLSkIkysGGPQIV
0 3
PPP2R5D (human) tQLSkIkysGGPQIV Y74-p
PPP2R5D (mouse) TQLSKIKYsGGPQIV Y67
PPP2R5D (rat) TQLSKIKYSGGPQIV Y94
S75-p
QLSkIkysGGPQIVk
Upstream
4 5
Kinase, in vitro:
  • PKACA (human)
PPP2R5D (human) QLSkIkysGGPQIVk S75-p
PPP2R5D (mouse) QLSKIKYsGGPQIVK S68-p
PPP2R5D (rat) QLSKIKYSGGPQIVK S95
K82-ub
sGGPQIVkKERRQss
0 1
PPP2R5D (human) sGGPQIVkKERRQss K82-ub
PPP2R5D (mouse) sGGPQIVKKERRQss K75
PPP2R5D (rat) SGGPQIVKKERRQSs K102
S88-p
VkKERRQsssRFNLs
Upstream
3 135
Treatment
  • nocodazole
PPP2R5D (human) VkKERRQsssRFNLs S88-p
PPP2R5D (mouse) VKKERRQssFPFNLN S81-p
PPP2R5D (rat) VKKERRQSsSRFNLS S108
S89-p
kKERRQsssRFNLsk
Upstream
0 229
Treatment
  • nocodazole
PPP2R5D (human) kKERRQsssRFNLsk S89-p
PPP2R5D (mouse) KKERRQssFPFNLNK S82-p
PPP2R5D (rat) KKERRQSsSRFNLSK S109-p
S90-p
KERRQsssRFNLskN
Upstream
0 77
Treatment
  • CXCL12
PPP2R5D (human) KERRQsssRFNLskN S90-p
PPP2R5D (mouse) KERRQssFPFNLNKN F83
PPP2R5D (rat) KERRQSsSRFNLSKN S110
S95-p
sssRFNLskNRELQk
0 12
PPP2R5D (human) sssRFNLskNRELQk S95-p
PPP2R5D (mouse) ssFPFNLNKNRELQK N88
PPP2R5D (rat) SsSRFNLSKNRELQK S115
K96-ub
ssRFNLskNRELQkL
0 2
PPP2R5D (human) ssRFNLskNRELQkL K96-ub
PPP2R5D (mouse) sFPFNLNKNRELQKL K89
PPP2R5D (rat) sSRFNLSKNRELQKL K116
K102-ub
skNRELQkLPALkDs
0 1
PPP2R5D (human) skNRELQkLPALkDs K102-ub
PPP2R5D (mouse) NKNRELQKLPALKDS K95
PPP2R5D (rat) SKNRELQKLPALKDS K122
K107-ub
LQkLPALkDsPTQER
0 1
PPP2R5D (human) LQkLPALkDsPTQER K107-ub
PPP2R5D (mouse) LQKLPALKDSPTQER K100
PPP2R5D (rat) LQKLPALKDSPTQER K127
S109-p
kLPALkDsPTQEREE
0 1
PPP2R5D (human) kLPALkDsPTQEREE S109-p
PPP2R5D (mouse) KLPALKDSPTQEREE S102
PPP2R5D (rat) KLPALKDSPTQEREE S129
K121-ub
REELFIQkLRQCCVL
0 3
PPP2R5D (human) REELFIQkLRQCCVL K121-ub
PPP2R5D (mouse) REELFIQKLRQCCVL K114
PPP2R5D (rat) REELFIQKLRQCCVL K141
K140-ub
SDPLSDLkFKEVKRA
0 3
PPP2R5D (human) SDPLSDLkFKEVKRA K140-ub
PPP2R5D (mouse) SDPLSDLKCKEVKRA K133
PPP2R5D (rat) SDPLSDLKFKEVKRA K160
K367-ub
PVIVGLLkFWPkTHS
0 4
PPP2R5D (human) PVIVGLLkFWPkTHS K367-ub
PPP2R5D (mouse) PVIVGLLkFWPKTHS K360-ub
PPP2R5D (rat) PVIVGLLKFWPKTHS K387
K371-ub
GLLkFWPkTHSPKEV
0 1
PPP2R5D (human) GLLkFWPkTHSPKEV K371-ub
PPP2R5D (mouse) GLLkFWPKTHSPKEV K364
PPP2R5D (rat) GLLKFWPKTHSPKEV K391
K409-ub
PLFRQLAkCVSSPHF
0 2
PPP2R5D (human) PLFRQLAkCVSSPHF K409-ub
PPP2R5D (mouse) PLFRQLAkCVSSPHF K402-ub
PPP2R5D (rat) PLFRQLAKCVSSPHF K429
Y430
LYYWNNEYIMSLISD
0 1
PPP2R5D (human) LYYWNNEYIMSLISD Y430
PPP2R5D (mouse) LYYWNNEyIMsLIsD Y423-p
PPP2R5D (rat) LYYWNNEYIMSLISD Y450
S433
WNNEYIMSLISDNAA
0 1
PPP2R5D (human) WNNEYIMSLISDNAA S433
PPP2R5D (mouse) WNNEyIMsLIsDNAA S426-p
PPP2R5D (rat) WNNEYIMSLISDNAA S453
S436
EYIMSLISDNAARVL
0 1
PPP2R5D (human) EYIMSLISDNAARVL S436
PPP2R5D (mouse) EyIMsLIsDNAARIL S429-p
PPP2R5D (rat) EYIMSLISDNAARVL S456
Y451-p
PIMFPALyRNSKSHW
0 4
PPP2R5D (human) PIMFPALyRNSKSHW Y451-p
PPP2R5D (mouse) PIMFPALYRNSKSHW Y444
PPP2R5D (rat) PIMFPALYRNSKSHW Y471
T461-p
SKSHWNKtIHGLIYN
0 5
PPP2R5D (human) SKSHWNKtIHGLIYN T461-p
PPP2R5D (mouse) SKSHWNKtIHGLIYN T454-p
PPP2R5D (rat) SKSHWNKTIHGLIYN T481
K479-ub
LFMEMNQkLFDDCTQ
0 1
PPP2R5D (human) LFMEMNQkLFDDCTQ K479-ub
PPP2R5D (mouse) LFMEMNQKLFDDCTQ K472
PPP2R5D (rat) LFMEMNQKLFDDCTQ K499
Y488-p
FDDCTQQykAEKQKG
0 26
PPP2R5D (human) FDDCTQQykAEKQKG Y488-p
PPP2R5D (mouse) FDDCTQQyKAEKQKG Y481-p
PPP2R5D (rat) FDDCTQQYKAEKQKG Y508
K489-ub
DDCTQQykAEKQKGR
0 1
PPP2R5D (human) DDCTQQykAEKQKGR K489-ub
PPP2R5D (mouse) DDCTQQyKAEKQKGR K482
PPP2R5D (rat) DDCTQQYKAEKQKGR K509
K500-ub
QKGRFRMkEREEMWQ
0 1
PPP2R5D (human) QKGRFRMkEREEMWQ K500-ub
PPP2R5D (mouse) QKGRFRMKEREEMWQ K493
PPP2R5D (rat) QKGRFRMKEREEMWQ K520
K508-ub
EREEMWQkIEELARL
0 4
PPP2R5D (human) EREEMWQkIEELARL K508-ub
PPP2R5D (mouse) EREEMWQKIEELARL K501
PPP2R5D (rat) EREEMWQKIEELARL K528
Y519-p
LARLNPQyPMFrAPP
0 3
PPP2R5D (human) LARLNPQyPMFrAPP Y519-p
PPP2R5D (mouse) LARLNPQYPMFRAPP Y512
PPP2R5D (rat) LARLNPQYPMFRAPP Y539
R523-m1
NPQyPMFrAPPPLPP
0 1
PPP2R5D (human) NPQyPMFrAPPPLPP R523-m1
PPP2R5D (mouse) NPQYPMFRAPPPLPP R516
PPP2R5D (rat) NPQYPMFRAPPPLPP R543
Y532-p
PPPLPPVysMEtEtP
0 7
PPP2R5D (human) PPPLPPVysMEtEtP Y532-p
PPP2R5D (mouse) PPPLPPVYSMETEtP Y525
PPP2R5D (rat) PPPLPPVYSMETEtP Y552
S533-p
PPLPPVysMEtEtPT
0 1
PPP2R5D (human) PPLPPVysMEtEtPT S533-p
PPP2R5D (mouse) PPLPPVYSMETEtPT S526
PPP2R5D (rat) PPLPPVYSMETEtPT S553
T536-p
PPVysMEtEtPTAED
0 1
PPP2R5D (human) PPVysMEtEtPTAED T536-p
PPP2R5D (mouse) PPVYSMETEtPTAED T529
PPP2R5D (rat) PPVYSMETEtPTAED T556
T538-p
VysMEtEtPTAEDIQ
0 7
PPP2R5D (human) VysMEtEtPTAEDIQ T538-p
PPP2R5D (mouse) VYSMETEtPTAEDIQ T531-p
PPP2R5D (rat) VYSMETEtPTAEDIQ T558-p
K548-ub
AEDIQLLkRTVEtEA
0 3
PPP2R5D (human) AEDIQLLkRTVEtEA K548-ub
PPP2R5D (mouse) AEDIQLLKRTVETEA K541
PPP2R5D (rat) AEDIQLLKRTVETEA K568
T553-p
LLkRTVEtEAVQMLk
0 1
PPP2R5D (human) LLkRTVEtEAVQMLk T553-p
PPP2R5D (mouse) LLKRTVETEAVQMLK T546
PPP2R5D (rat) LLKRTVETEAVQMLK T573
K560-ub
tEAVQMLkDIKKEKV
0 1
PPP2R5D (human) tEAVQMLkDIKKEKV K560-ub
PPP2R5D (mouse) TEAVQMLKDIKKDKV K553
PPP2R5D (rat) TEAVQMLKDIKKDKV K580
K572-ub
EKVLLRRksELPQDV
0 1
PPP2R5D (human) EKVLLRRksELPQDV K572-ub
PPP2R5D (mouse) DKVLLRRKsELPQDV K565
PPP2R5D (rat) DKVLLRRKsELPQDV K592
S573-p
KVLLRRksELPQDVy
Upstream
Downstream
7 391
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • PKACA (human)
Phosphatases, in vitro:
  • PPP1CA (human)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • PPP2R5D (rat)
Treatment
  • angiotensin_2
  • aphidicolin
  • CGP_20712A
  • H-89
  • ICI-118,551
  • isoproterenol
  • metastatic potential
  • N6-benzoyl-cAMP
  • PKI
  • propranolol
PPP2R5D (human) KVLLRRksELPQDVy S573-p
PPP2R5D (mouse) KVLLRRKsELPQDVy S566-p
PPP2R5D (rat) KVLLRRKsELPQDVY S593-p
Y580-p
sELPQDVytIkALEA
0 95
PPP2R5D (human) sELPQDVytIkALEA Y580-p
PPP2R5D (mouse) sELPQDVytIKALEA Y573-p
PPP2R5D (rat) sELPQDVYTIKALEA Y600
T581-p
ELPQDVytIkALEAH
0 23
PPP2R5D (human) ELPQDVytIkALEAH T581-p
PPP2R5D (mouse) ELPQDVytIKALEAH T574-p
PPP2R5D (rat) ELPQDVYTIKALEAH T601
K583-ub
PQDVytIkALEAHkR
0 2
PPP2R5D (human) PQDVytIkALEAHkR K583-ub
PPP2R5D (mouse) PQDVytIKALEAHKR K576
PPP2R5D (rat) PQDVYTIKALEAHKR K603
K589-ub
IkALEAHkRAEEFLT
0 1
PPP2R5D (human) IkALEAHkRAEEFLT K589-ub
PPP2R5D (mouse) IKALEAHKRAEEFLT K582
PPP2R5D (rat) IKALEAHKRAEEFLT K609
S598-p
AEEFLTAsQEAL___
0 14
PPP2R5D (human) AEEFLTAsQEAL___ S598-p
PPP2R5D (mouse) AEEFLTAsQEAL___ S591-p
PPP2R5D (rat) AEEFLTASQEAL___ S618